d-4-chloro-17 beta-hydroxy-3-oxo-17 alpha-methylandrosta-1,4-diene has been researched along with Antithrombin III Deficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brauckhoff, KF; Liedloff, H | 1 |
1 trial(s) available for d-4-chloro-17 beta-hydroxy-3-oxo-17 alpha-methylandrosta-1,4-diene and Antithrombin III Deficiency
Article | Year |
---|---|
[Drug prevention of thromboembolism in elective hip surgery with reference to thrombophilic conditions].
Topics: Aged; Antithrombin III Deficiency; Blood Coagulation Tests; Clinical Trials as Topic; Dihydroergotamine; Drug Combinations; Female; Fibrinolysis; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Testosterone; Thromboembolism | 1989 |